Cholinesterase (ChE) Inhibitors

AChE

BChE

Cholinesterase (ChE) Inhibitors, Agonists, Antagonists, Activators & Chemicals

Product Name	AChE	BChE	Purity
Donepezil Hydrochloride	AChE		99.92%
Donepezil	AChE		99.87%
TMPyP4 tosylate	AChE		≥98.0%
Galanthamine	AChE		99.96%
AChE/BChE-IN-24	AChE, IC₅₀: 16.38 μM	BChE, IC₅₀: 10.44 μM
Rivastigmine	AChE	BChE	99.93%
α-NETA	AChE		≥98.0%
Garcinol	AChE	BChE	≥99.0%
Imperatorin	AChE	BChE	98.72%
Physostigmine salicylate	AChE		99.37%
Scopoletin	AChE		99.89%
(-)-Huperzine A	AChE		99.74%
Linarin	AChE		98.00%
Buntanetap	AChE		99.71%
Epiberberine chloride	AChE	BChE	99.02%
Isoimperatorin	AChE		99.61%
Rivastigmine tartrate	AChE		99.03%
Pyridostigmine bromide	AChE		99.93%
Tacrine	AChE, IC₅₀: 109 nM		99.91%
Sinapine	AChE		99.96%
Tacrine hydrochloride	AChE	BChE	99.95%
Timosaponin AIII	AChE		99.73%
Chlorpyrifos	AChE		99.94%
Ethopropazine hydrochloride	AChE	BChE	99.66%
Jatrorrhizine chloride	AChE		99.88%
Corydaline	AChE		99.70%
Sinapine thiocyanate	AChE		99.74%
Itopride hydrochloride	AChE		99.85%
Nodakenin	AChE		98.76%
Tacrine hydrochloride (hydrate)	AChE	BChE	99.98%
Pralidoxime chloride	AChE		99.73%
Galanthamine hydrobromide	AChE		99.93%
Rhodiosin	AChE		99.36%
Cyanidin-3-O-galactoside chloride	AChE		99.20%
Coumaran	AChE		99.54%
Acephate	AChE		≥98.0%
(-)-Carvone	eel AChE, Ki: 2.19 mM		99.91%
N-p-trans-Coumaroyltyramine	AChE		98.78%
Rhodionin	AChE		98.78%
Tenuifolin	AChE		99.24%
RPR121056	AChE		99.59%
Phenserine	AChE		99.55%
Physostigmine hemisulfate	AChE		≥99.0%
Pralidoxime iodide	AChE		≥98.0%
(±)-Huperzine A	AChE		98.73%
β-NETA	AChE		≥98.0%
Benactyzine hydrochloride		BChE, Ki: 0.01 mM	99.02%
Drofenine hydrochloride		BChE	98.10%
Mca-YVADAP-Lys(Dnp)-OH TFA	AChE		98.85%
Fenchlorphos	AChE		99.87%
Ladostigil hydrochloride	AChE, IC₅₀: 31.8 μM		99.94%
Pirimiphos-methyl	AChE		98.00%
Galanthaminone	AChE		99.63%
Acotiamide monohydrochloride trihydrate	AChE		99.49%
PE154	AChE, IC₅₀: 280 pM	BChE, IC₅₀: 16 nM	99.01%
BChE-IN-17	eel AChE, IC₅₀: 686.4 μM	hBCHE, IC₅₀: 32.5 nM eqBCHE, IC₅₀: 10.5 nM	99.07%
Violanthin	AChE
Manghaslin	AChE		≥98.0%
Zanapezil fumarate	AChE		99.63%
Ebeiedinone	AChE	BChE	99.51%
Pirimicarb	AChE		99.50%
Anatoxin-a	AChE
Territrem B	AChE
Zanapezil	AChE		99.63%
Isorosmanol	AChE		98.08%
Polygalacic acid	AChE		98.92%
P11149	AChE		99.23%
SD-6	hAChE, IC₅₀: 0.907 μM	hBCHE, IC₅₀: 1.579 μM	≥98.0%
Sophoflavescenol	AChE	BChE	98.15%
AChE/BChE-IN-10	AChE, IC₅₀: 0.176 μM	BChE, IC₅₀: 0.47 μM	99.67%
Galanthamine N-Oxide	AChE	BChE	99.90%
Pitofenone hydrochloride	AChE		99.88%
(±)-Marmesin	AChE
Epiberberine	AChE	BChE	98.46%
Y13g dihydrochloride	AChE		99.89%
ASS234	AChE, IC₅₀: 350 nM	BChE, IC₅₀: 460 nM	99.6%
Swertianolin	AChE		99.54%
Dihydrowithaferin A	AChE		≥99.0%
PCS1055	hAChE, IC₅₀: 120 nM		98.02%
Z32439948		BChE, IC₅₀: 1.4 μM (^[1])
HDAC6-IN-5	AChE, IC₅₀: 0.72 μM
ZLMT-12	AChE, IC₅₀: 19.023 μM	BChE, IC₅₀: 2.768 μM
AChE/BChE-IN-1	AChE	BChE
AChE/BChE-IN-11	AChE, IC₅₀: 70 μM	BChE, IC₅₀: 71 μM
AChE-IN-46	AChE
Bis-(-)-8-demethylmaritidine	AChE
Carbonic anhydrase/AChE-IN-1	AChE, Ki: 5.07 nM
BChE-IN-38	AChE, Ki: 14.09 nM	BChE, Ki: 1.15 nM
tau/Aβ40 aggregation-IN-1	hAChE, IC₅₀: 16.10 μM	equine serum BChE, IC₅₀: 0.96 μM
Artanin	AChE, IC₅₀: 51 μM
BChE-IN-22		eqBCHE, IC₅₀: 0.53 μM
hCAI/II-IN-8	AChE, IC₅₀: 46.27 ±0.7 nM	BChE, IC₅₀: 43.38 ± 0. nM
AChE-IN-77	AChE, IC₅₀: 29.46 μM
Z164597606		hBCHE, IC₅₀: 1.7 μM eqBCHE, IC₅₀: 1.3 μM
KBR 2822	AChE
Multitarget AD inhibitor-2	AChE, IC₅₀: 0.14 μM	BChE, IC₅₀: 11.6 μM
hAChE/hBACE-1-IN-1	hBACE-1, IC₅₀: 0.23 μM hAChE, IC₅₀: 0.076 μM	hBCHE, IC₅₀: 1.204 μM
AChE-IN-60	AChE, IC₅₀: 27 nM	BChE, IC₅₀: 43 nM
BChE-IN-28	AChE, IC₅₀: 3691 nM	BChE, IC₅₀: 8 nM BChE, Ki: 12.16 nM
hCA I-IN-4	AChE, Ki: 21.21 nM	BChE, Ki: 7.65 nM
AChE-IN-22	AChE
BChE-IN-35		BChE
hAChE/hBuChE/GSK-3β-IN-1	hAChE, IC₅₀: 28.88 nM	hBCHE, IC₅₀: 131.90 nM
eeAChE-IN-3	RatAChE, IC₅₀: 0.49 μM EeAChE, IC₅₀: 0.54 μM	RatBuChE, IC₅₀: 8.54 μM
BChE-IN-31	AChE, IC₅₀: 5.9 μM	BChE, IC₅₀: 65 nM
H3R antagonist 4	hAChE, IC₅₀: 9.73 μM EeAChE, IC₅₀: 7.04 μM	eqBCHE, IC₅₀: 13.40 ~ 88 μM
hBChE-IN-2		hBCHE, IC₅₀: 0.67 μM
AChE/MAO-B-IN-3	hAChE, IC₅₀: 0.0257 μM
Dual AChE-MAO B-IN-3	EeAChE, IC₅₀: 0.58 ± 0.0 μM
Methyl ganoderate A acetonide	AChE
AChE/MAO-B-IN-4	AChE
AChE/BChE-IN-3 hydrochloride	AChE	BChE
Desoxypeganine	AChE, IC₅₀: 17 μM	BChE, IC₅₀: 2 μM
AChE-IN-75	AChE
CL-13		BChE, IC₅₀: 1.15 μM
AChE-IN-21	EeAChE, IC₅₀: 2.66 nM	RatBuChE, IC₅₀: 19.10 μM
AChE/BChE-IN-25	hAChE, IC₅₀: 7.9 nM	eqBCHE, IC₅₀: 0.79 nM
BChE-IN-10		BChE, IC₅₀: 6.4 μM
Kokusaginine	AChE, IC₅₀: 28.2 μM
AChE-IN-17	AChE
AChE-IN-10	AChE
AChE-IN-59	AChE, IC₅₀: 0.05 μM	BChE, IC₅₀: 4.68 μM
Bisnorcymserine		BChE, IC₅₀: 0.228 nM
BChE-IN-34		eqBCHE, IC₅₀: 25 nM
BChE/MAO-B-IN-1		BChE, IC₅₀: 375 nM
BChE-IN-5	AChE	BChE
AChE-IN-5	AChE
AChE/BChE-IN-23	hAChE, IC₅₀: 0.91 μM	hBCHE, IC₅₀: 1.02 μM eqBCHE, IC₅₀: 1.19 μM
AChE/BChE-IN-19	AChE, IC₅₀: 21.45 nM	BChE, IC₅₀: 18.42 nM
hAChE-IN-3	AChE, IC₅₀: 0.44 μM	BChE, IC₅₀: 0.08 μM
Fmoc-L-Val-OH-¹³C₅,¹⁵N	AChE		≥98%
AChE/BChE-IN-6	hAChE, IC₅₀: 2.248 μM	hBCHE, IC₅₀: 0.809 μM
AChE-IN-35	AChE, IC₅₀: 5.88 μM
AChE/BChE/MAO-B-IN-2	AChE, IC₅₀: 83.9 nM	BChE, IC₅₀: 31.2 nM
Broussonin A		BChE, IC₅₀: 4.16 μM
BuChE-IN-7		hBCHE, IC₅₀: 40 nM eqBCHE, IC₅₀: 80 nM
AChE-IN-64	AChE, IC₅₀: 36.9 μM
hAChE-IN-10	hAChE, IC₅₀: 6.34 nM
Manumycin B	AChE, IC₅₀: 15 mM
Xanthohumol I	AChE	BChE
AChE/MAO-IN-1	hAChE, IC₅₀: 0.0248 μM
Pitofenone	AChE
AChE-IN-34	AChE, IC₅₀: 3.98 μM AChE, Ki: 0.044 μM
Monarsen	AChE
AChE/BChE-IN-18	AChE, IC₅₀: 0.315 μM
Pralidoxime	AChE
MAO-B-IN-7	hAChE, IC₅₀: 41 nM
Isogarcinol	AChE, IC₅₀: 1.13 ± 0.0 μM	BChE, IC₅₀: 8.30 ± 0.0 μM
α-Amylase/α-Glucosidase-IN-7	AChE, IC₅₀: 9.25 μM	BChE, IC₅₀: 10.06 μM
S16–1029		hBCHE, IC₅₀: 48.1 nM eqBCHE, IC₅₀: 11.35 nM
BChE-IN-26	AChE, Ki: 35 μM	BChE, Ki: 1.6 μM
S21-1011		hBCHE, IC₅₀: 0.162 μM eqBCHE, IC₅₀: 0.059 μM
AChE-IN-52	AChE
AChE-IN-4	AChE, IC₅₀: 24.1 μM
AChE/hCA I-IN-1	AChE, IC₅₀: 302.2 nM
AChE-IN-63	hAChE, IC₅₀: 0.103 μM	hBCHE, IC₅₀: 10 μM
hBChE-IN-1	hAChE, IC₅₀: 7.84 ± 0.8 μM EeAChE, IC₅₀: 0.18 μM	hBCHE, IC₅₀: 0.0070 ± 0 μM equine serum BChE, IC₅₀: 0.088 μM
AChE-IN-24	AChE
Stemoninine	hAChE, IC₅₀: 5.52 μM
AChE-IN-8	AChE
Isoprocarb-d₃	AChE
eeAChE-IN-2	AChE
AChE/BuChE/MAO-B-IN-2	AChE, IC₅₀: 5.3 μM	BChE, IC₅₀: 12.4 μM
ChE/Aβ1-42-IN-1	AChE
K203	AChE
AChE-IN-72	AChE, IC₅₀: 0.59 μM	BChE, IC₅₀: 5.02 μM
hBChE-IN-3	AChE, IC₅₀: 7.4 nM	BChE, IC₅₀: 1.9 nM
CEase-IN-1	AChE, IC₅₀: 45.9 μM
AChE-IN-68	hAChE, IC₅₀: 0.040 ± 0. μM	hBCHE, IC₅₀: >1000 μM
AChE-IN-9	AChE, IC₅₀: 0.4 μM
BChE-IN-11		BChE, IC₅₀: 2.1 ± 0.3 μM
Velnacrine	AChE, IC₅₀: 3.27 μM
BChE-IN-12		BChE, IC₅₀: 2.3 μM
hAChE-IN-8	hAChE, IC₅₀: 0.486 μM	hBCHE, IC₅₀: 0.542 μM
Protriptyline	AChE, IC₅₀: 0.06 mM
AChE/PDE4-IN-1	AChE, IC₅₀: 0.28 μM
AChE/BuChE-IN-3	AChE, IC₅₀: 0.65 μM	BChE, IC₅₀: 5.77 μM
hAChE/hBACE-1-IN-2	hBACE-1, IC₅₀: 0.38 μM hAChE, IC₅₀: 0.113 μM	hBCHE, IC₅₀: 1.48 μM
BChE-IN-39	AChE, IC₅₀: 3.98 μM	BChE, IC₅₀: 0.08 μM
MR2938	AChE, IC₅₀: 5.04 ± 0.7 μM	BChE, IC₅₀: >20 μM
AChE-IN-47	AChE
BChE-IN-36	EeAChE, IC₅₀: 72.1 nM	eqBCHE, IC₅₀: 4.2 nM
AChE/BChE-IN-16	hAChE, IC₅₀: 30 nM	hBCHE, IC₅₀: 48 nM
BuChE-IN-11		hBCHE, IC₅₀: 0.44 μM
(Rac)-Sclerone	AChE, IC₅₀: 192.65 ± 1 μg/mL
Azamethiphos	AChE
BChE-IN-19		BChE, IC₅₀: 0.04 μM
hAChE/hBACE-1-IN-4	hAChE, IC₅₀: 0.283 μM	hBCHE, IC₅₀: 0.231 μM
AChE/BuChE-IN-6	AChE, IC₅₀: 1.24 μg/mL	BChE, IC₅₀: 1.85 μg/mL
AChE/BChE-IN-17	AChE, IC₅₀: 125.06 ± 2 nM	BChE, IC₅₀: 119.68 ± 2 nM
BuChE-IN-12		BChE, IC₅₀: 0.52 nM
AChE-IN-11	AChE
AChE-IN-44	AChE
BChE-IN-15	hAChE, IC₅₀: 558.6 nM	hBCHE, IC₅₀: 1.76 nM
K1833	hAChE, IC₅₀: 58 μM	hBCHE, IC₅₀: 0.57 μM
AChE-IN-28	AChE, IC₅₀: 0.2 nM
Blestrin D		BChE, IC₅₀: 8.1 μM
hAChE-IN-6	hAChE, IC₅₀: 0.16 μM	hBCHE, IC₅₀: 0.69 μM
AChE/Aβ-IN-4	AChE, IC₅₀: 1.72 ± 0.1 μM
AChE/Aβ-IN-3	AChE, IC₅₀: 1.29 μM
eeAChE-IN-1	AChE
hAChE/Aβ1-42-IN-1	AChE
MAO-A/B-IN-3	AChE, IC₅₀: 1370 nM
Itopride	AChE
AChE/BChE/MAO-B-IN-3	hAChE, IC₅₀: 0.0473 μM	hBCHE, IC₅₀: 0.0782 μM
BChE-IN-29	AChE, IC₅₀: 0.74 μM	BChE, IC₅₀: 0.075 μM
K027	AChE	BChE
BChE-IN-32		hBCHE, IC₅₀: 0.109 μM
α-Glucosidase-IN-68	AChE, IC₅₀: 0.774 μM	BChE, IC₅₀: 0.793 μM
AChE/BChE-IN-12	EeAChE, IC₅₀: 2.57 ± 0.3 μM	eqBCHE, IC₅₀: 3.26 ± 0.1 μM
AChE-IN-51	AChE, IC₅₀: 84 nM	BChE, IC₅₀: 97 nM
AChE/BACE1/GSK3β-IN-1	AChE, IC₅₀: 1 μM
NDs-IN-1	hAChE	hBCHE
hAChE-IN-9	hAChE, IC₅₀: 0.05 μM	hBCHE, IC₅₀: 2.85 μM
AChE-IN-19	AChE
AChE-IN-20	AChE, IC₅₀: 397.32 nM AChE, Ki: 335.76 nM
AChE/BChE-IN-20	AChE, IC₅₀: 34.81 μM	BChE, IC₅₀: 20.66 μM
AChE-IN-69	AChE, IC₅₀: 1.67 μM
SBN-284	hAChE, IC₅₀: 0.31 μM EeAChE, IC₅₀: 0.37 μM	eqBCHE, IC₅₀: 0.29 μM
Kuwanon U	AChE, IC₅₀: 19.69 μM AChE, IC₅₀: 6.48 μM	BChE, Ki: 10.11 μM BChE, Ki: 9.59 μM
Isograndifoliol	AChE, IC₅₀: 342.9 μM	BChE, IC₅₀: 0.9 μM
BChE-IN-33		BChE, IC₅₀: 14.78 nM
MR33317	AChE, IC₅₀: 41 nM
Desoxypeganine hydrochloride	AChE, IC₅₀: 17 μM	BChE, IC₅₀: 2 μM
AChE/CA I-IN-1	AChE, Ki: 1.85 μM
AChE/BuChE/MAO-B-IN-1	hAChE, IC₅₀: 4.8 μM	hBCHE, IC₅₀: 13.7 μM
Methylene Violet 3RAX	AChE, Ki: 1.58 μM	BChE, Ki: 0.51 μM
Memoquin	hAChE, IC₅₀: 1.55 nM
AChE-IN-67	AChE, IC₅₀: 0.033±0.00 μM	BChE, IC₅₀: >100 μM
AChE-IN-55	EeAChE, IC₅₀: 4.8 μM
Lycodoline		BChE, IC₅₀: 667 μM
Dual AChE-MAO B-IN-4	AChE, IC₅₀: 261 nM
TRV-7019		BChE	99.64%
hAChE-IN-2	hAChE, IC₅₀: 0.71 μM
BChE-IN-16		hBCHE, IC₅₀: 3.8 nM
AChE-IN-56	AChE
AChE/MAO-IN-2	AChE, IC₅₀: 0.0224 μM
Y13g	AChE
AChE/BuChE-IN-5	AChE, IC₅₀: 46.9 nM	RatBuChE, IC₅₀: 3.5 nM
hAChE-IN-1	hAChE, IC₅₀: 1.09 μM
ChEs/MAOs-IN-2	AChE, IC₅₀: 0.30 μM	BChE, IC₅₀: 0.40 μM
Flucopride	AChE, IC₅₀: 24 nM
SB-1436	EeAChE, IC₅₀: 0.176 μM EeAChE, Ki: 0.046 μM	eqBCHE, IC₅₀: 0.37 μM eqBCHE, Ki: 0.115 μM
WAY-361789	AChE
AL284	AChE
7-Methoxytacrine	hAChE, IC₅₀: 10.5 μM	hBCHE, IC₅₀: 21 μM
Benactyzine		BChE, Ki: 0.01 mM
1,2-Didehydrotanshinone IIA		BChE, IC₅₀: 5.98 μM
T14-A24	AChE, Ki: 22 nM
Lucidadiol	AChE, IC₅₀: 31.03 μM	BChE, IC₅₀: 156.27 μM
Buxbodine B	AChE, IC₅₀: 50 μM
MHP 133	AChE, Ki: 69 μM
p-Xylene bis(pyridinium bromide)	hAChE, IC₅₀: 1540 μM	BChE, IC₅₀: 529 μM
Donepezil N-oxide	AChE
TAE-1	AChE

MedChemExpress (MCE) 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务，不为任何个人或者非科研性质的、非用于药证申报使用等其他用途提供服务。	站点地图隐私声明
沪ICP备15051369号-4 上海工商沪公网安备31011502019417 沪(浦)应急管危经许[2021]201709(QFYS) 营业执照（三证合一）
Copyright © 2013-2025 MedChemExpress. All Rights Reserved.

MedChemExpress (MCE) 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务，不为任何个人或者非科研性质的、非用于药证申报使用等其他用途提供服务。

站点地图隐私声明

沪ICP备15051369号-4